This is a firm-fixed-price definitive contract awarded by the Department of Veterans Affairs (VA) to Myriad Genetics Inc. for $589,712.00 to provide Prolaris genetic testing services to the VA Long Beach Healthcare System. The contract has a 1-year base period with two 1-year option periods, and is for performing quantitative PCR analysis on prostate biopsy samples to measure gene expression and generate clinical reports to assess prostate cancer aggressiveness and guide treatment. This contract award is not associated with a larger vehicle and does not use any set-aside designations. Myriad Genetics is a molecular diagnostic company that specializes in genetic tests for cancer risk assessment and treatment guidance.
Generated 1/29/25, 9:23 AM